Selectivity Filter Mutation in NaV1.5 Promotes Ventricular Tachycardia
JACC: Clinical Electrophysiology · 2026
DOI: 10.1016/j.jacep.2025.12.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026. Verfasst von Zoja Selimi und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University…. Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Tachycardia, Ventricular. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, NINDS.
Abstract (Originalsprache)
BACKGROUND: Loss-of-function mutations in the SCN5A gene, which encodes for the predominant cardiac NaV isoform, NaV1.5, result in either deficiency in the channel expression or function. Impaired NaV1.5 expression and function underlie reduced peak Na+ current (INa) and result in ventricular conduction velocity slowing, predisposing the heart to conduction block and ventricular arrhythmias clinically associated with Brugada syndrome (BrS). Recently, a missense mutation in NaV1.5 selectivity filter (DEKA motif), K1419E (DEEA), has been identified in patients with BrS. Despite early characterization of mutations in selectivity filter of other NaV isoforms, little is known about the impact of DEEA on NaV1.5 function as well as on cardiac electrophysiology. OBJECTIVES: In this study, we generated a mouse heterozygous for NaV1.5 DEEA to characterize the mutation and investigate the outcome of this functionally deficient NaV1.5 variant on cardiac electrophysiology and arrhythmias. METHODS: Patch clamp electrophysiology studies were conducted in Chinese hamster ovary cells expressing the DEEA variant, along with immunolabeling, voltage optical mapping, and in vivo electrocardiography studies in a DEEA murine model of BrS. RESULTS: A heterologous expression system and isolated cardiomyocytes revealed lower current density and unchanged NaV1.5 expression in DEEA vs wild type (DEKA). On the organ level, optical mapping revealed conduction velocity slowing in DEEA hearts, which was accentuated by flecainide, resulting in in vivo ventricular arrhythmias. CONCLUSIONS: Overall, to our knowledge, we provide the first mechanistic insight into the proarrhythmic consequences of a functionally deficient BrS mutation in NaV1.5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Division of Pharmaceutics…
- The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Department of Biomedical…
- The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Department of Physiology…
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
- NINDS
- NHLBI
Zitieren
APA
Selimi, Z., Tarasov, M., Meng, X., Dias, P., Moise, B., Liu, H., Cavus, O., Nassal, D., Veeraraghavan, R., & Radwański, P. B. (2026). Selectivity Filter Mutation in NaV1.5 Promotes Ventricular Tachycardia. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2025.12.033
Vancouver
Selimi Z, Tarasov M, Meng X, Dias P, Moise B, Liu H, et al. Selectivity Filter Mutation in NaV1.5 Promotes Ventricular Tachycardia. JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2025.12.033
BibTeX
@article{Selimi2026,
author = {Selimi, Zoja and Tarasov, Mikhail and Meng, Xiaolei and Dias, Patrícia and Moise, Bianca and Liu, Haiyan and Cavus, Omer and Nassal, Drew and Veeraraghavan, Rengasayee and Radwański, Przemysław B},
title = {Selectivity Filter Mutation in NaV1.5 Promotes Ventricular Tachycardia},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
doi = {10.1016/j.jacep.2025.12.033}
}
EUVIMED